TRVN

Trevena, Inc.

0.59 USD
+0.01 (+1.26%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Trevena, Inc. stock is down -8.08% since 30 days ago. The next earnings date is Mar 28, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 27.27% of the previous 10 March’s closed higher than February.

About Trevena, Inc.

Trevena focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain.